Skip to main content
    O

    Owlet Inc (OWLT)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $4.43
    +0.02 (+0.45%)

    Market Cap: $135.30M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    62%(13/21)
    Avg Surprise
    -33.97%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.06 - $0.05
    2 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$0.01-174.6%
    60d ago$0.01-174.6%
    30d ago$-0.01+50.0%
    7d ago$-0.01+50.0%
    Current$-0.01
    Revenue Consensus
    $30M
    Range$29M - $31M
    5 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.48
    Range$0.48 - $0.48
    1 analysts
    Revenue Consensus
    $37M
    Range$36M - $39M
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.48---
    Sep 26EST
    		-$-0.01---
    Jun 26
    Reported Aug 11
    		$-0.05$-0.08+37.50%Beat+66.7%
    Mar 26
    Reported May 7
    		$-0.09N/A+52.63%Beat-28.6%
    Dec 25
    Reported Mar 5
    		$-0.03N/A+73.52%Beat+57.1%
    Sep 25
    Reported Nov 13
    		$0.03N/A+115.00%Beat+0.0%
    Jun 25
    Reported Aug 7
    		$-0.15N/A+55.88%Beat+50.7%
    Mar 25
    Reported May 8
    		$-0.07N/A+70.83%Beat+82.1%
    Dec 24
    Reported Mar 4
    		$-0.07N/A+85.42%Beat+41.7%
    Sep 24
    Reported Nov 13
    		$0.03N/A+112.50%Beat+103.6%
    Jun 24
    Reported Aug 12
    		$-0.30$-0.19-60.26%Miss+45.6%
    Mar 24
    Reported May 6
    		$-0.39$-0.14-178.57%Miss+65.2%
    Dec 23
    Reported Mar 7
    		$-0.12$-0.04-200.00%Miss+14.3%
    Sep 23
    Reported Nov 13
    		$-0.84$-0.36-133.33%Miss+64.7%
    Jun 23
    Reported Aug 14
    		$-0.56$-0.37-51.35%Miss+75.0%
    Mar 23
    Reported May 11
    		$-1.12$-1.26+11.11%Beat+52.9%
    Dec 22
    Reported Mar 15
    		$-0.14$-0.15+6.67%Beat+51.7%
    Sep 22
    Reported Nov 14
    		$-2.38$-2.38+0.00%Beat-30.8%
    Jun 22
    Reported Aug 11
    		$-2.24$-2.52+11.11%Beat+46.7%
    Mar 22
    Reported May 11
    		$-2.38$-2.45+2.86%Beat-4660.0%
    Dec 21
    Reported Mar 7
    		$-0.29$-0.14-107.14%Miss-2800.0%
    Sep 21
    Reported Nov 10
    		$-1.82$-0.91-100.00%Miss-
    Jun 21
    Reported Aug 12
    		$-4.20$-0.68-517.65%Miss-
    Mar 21
    Reported May 19
    		$-0.05N/AN/ABeat-
    Dec 20
    Reported Mar 25
    		$-0.01N/AN/ABeat-
    Sep 20
    Reported Nov 13
    		$0.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-31.64EV/EBITDAN/A
    Price/FCF-13.35xFCF Yield-7.49%
    Profitability
    Profit Margin-8.44%Operating Margin5.14%
    ROE-526.00%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage-2.18x
    Current Ratio1.64xQuick Ratio1.35x
    Trading Statistics
    Beta1.91Avg Volume153.75K
    52-Week High$16.9452-Week Low$4.19

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.72
    SMA 20$4.92
    SMA 50$5.11
    SMA 200$7.01
    EMA 10$4.68
    EMA 20$4.81
    EMA 50$5.03
    EMA 200$6.26

    MACD

    Line: -0.15Signal: -0.10Hist: -0.05

    ADX

    ADX: 14.6+DI: 17.6-DI: 26.9

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down100.0
    PSAR$5.20

    Bollinger Bands

    Upper Band$5.51
    Lower Band$4.33
    %B Position2395%(Upper)
    Band Width0.08

    RSI (14-Day)

    Neutral
    35.2

    Momentum Oscillators

    Stoch %K6.2
    Stoch %D7.5
    Williams %R-91.7
    ROC (10d)-11.9%
    Momentum-0.60
    CCI (20d)-137.5
    MFI (14d)36.0

    Volatility Measures

    ATR (14d)$0.25(5.6%)
    StdDev (20d)0.29
    Hist Vol62.1%(High)

    Volume Flow

    VWAP$4.43
    OBV-7.3M
    AD Line-3.0M
    CMF (20d)0.001

    Volume Metrics

    Avg Vol (20d)157.3K
    Vol Ratio0.9x
    VWMA (20d)$4.95

    Pivot Points

    R3$4.84
    R2$4.76
    R1$4.58
    Pivot Point$4.50
    S1$4.32
    S2$4.24
    S3$4.06

    Advanced Oscillators

    TSI-16.89
    Ultimate Osc33.5
    KST-57.23

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$33.90M$22.46M$26.55M$31.99M$26.06M$21.10M$20.50M$22.12M$20.70M$14.75M$21.00M$9.18M
    Cost of Revenue$12.10M$10.22M$13.93M$15.79M$12.68M$9.78M$9.50M$10.58M$10.45M$8.20M$11.13M$5.85M
    Gross Profit$21.80M$12.24M$12.63M$16.20M$13.38M$11.33M$11.00M$11.55M$10.25M$6.55M$9.87M$3.33M
    Operating Expenses$20.10M$17.73M$17.51M$14.98M$15.30M$14.00M$18.30M$16.37M$12.50M$12.29M$12.95M$11.21M
    R&D$4.60M$3.96M$3.63M$3.79M$3.75M$2.90M$2.50M$2.56M$2.35M$2.35M$2.29M$2.43M
    SG&A$9.60M$9.30M$8.65M$6.27M$7.23M$7.09M$11.80M$9.79M$6.29M$6.05M$6.91M$5.45M
    Operating Income$1.70M$-5,442,000$-4,887,000$1.22M$-1,919,000$-2,671,000$-7,300,000$-4,822,000$-2,244,000$-5,746,000$-3,082,000$-7,880,000
    Interest Income$0$0$0$0$0$0$0$0$20,000$0$0$0
    Interest Expense$700,000$683,000$588,000$860,000$979,000$991,000$1.38M$100,000$8,000$161,000$193,000$134,000
    Income Before Tax$-600,000$-3,329,000$-9,216,000$4.14M$-37,614,000$3.04M$-8,452,000$-5,611,000$-1,125,000$3.27M$-6,921,000$-5,641,000
    Income Tax Expense$0$7,000$-26,000$9,000$33,000$12,000$600,000$1.15M$22,000$5,000$5,000$1.32M
    Net Income$-600,000$-3,336,000$-9,190,000$4.13M$-37,647,000$3.02M$-9,052,000$-5,611,000$-1,147,000$3.27M$-6,926,000$-5,641,000
    EBITDA$311,000$-2,461,000$-8,463,000$5.16M$-37,492,000$4.18M$-7,462,000$-5,345,000$-656,000$3.90M$-6,239,000$-4,982,000
    EBIT$100,000$-2,646,000$-8,628,000$5.00M$-37,614,000$4.03M$-7,643,000$-5,611,000$-1,125,000$3.44M$-6,728,000$-5,507,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OWLT

    OWLT Valuation and Fair Value

    P/E
    -31.6x
    P/FCF
    -13.4x
    P/B
    3.2x
    See GNG's fair value

    OWLT Profitability: Margins, ROIC and FCF

    Gross margin
    54.7%
    Operating margin
    5.1%
    Net margin
    -8.4%
    ROE
    -526.0%
    FCF margin
    -8.2%
    FCF yield
    -7.5%

    OWLT Competitors

    CompanyTicker
    Anavex Life Sciences CorpAVXL
    AN2 Therapeutics IncANTX
    Atrium Therapeutics, Inc. Common StockRNA
    Tiziana Life Sciences LtdTLSA
    Molecular Partners AG ADRMOLN
    Voyager Therapeutics IncVYGR
    Codexis IncCDXS
    Health Catalyst IncHCAT

    Sector: Healthcare

    OWLT Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    0
    Buy
    5
    Hold
    0
    Sell
    0
    Strong Sell
    0

    OWLT Bull Case vs Bear Case

    Bull case

    • OWLT beat EPS estimates in 100.0% of its last 8 reported quarters.
    • OWLT grew quarterly revenue 29.9% year over year.
    • 100.0% of OWLT's analyst ratings are Buy or Strong Buy.

    Bear case

    • OWLT has a -8.4% net profit margin.

    OWLT Earnings: Beat Rate and Next Report

    Beat rate
    8 of 8 quarters (100.0%)
    Average surprise
    75.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.01
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 2 down

    Frequently Asked Questions About OWLT

    Does OWLT pay dividends?

    Owlet Inc (OWLT) does not currently pay a regular dividend.

    What is OWLT's market cap?

    Owlet Inc (OWLT) has a market capitalization of $135.30M with a current stock price of $4.43.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In